Patent Assignment
Reel/Frame 056044/0988
Security Interest
Recorded: 2021-04-26
Pages: 7
Assignor
ESPERION THERAPEUTICS, INC.
Executed: 2021-04-26
Assignee
EIGER III SA LLC, AS PURCHASER AGENT
1700 BROADWAY, 37TH FLOOR, NEW YORK, NEW YORK, 10019
Covered Properties
(16)
Hydroxy compounds and compositions for cholesterol management and related uses
Application:
60/441,795 →
Hydroxyl Compounds and Compositions for Cholesterol Management and Related Uses
Application:
17/163,810 →
Publication:
US 2021/0395175
Methods of Making Bempedoic Acid and Compositions of the Same
Application:
62/864,873 →
Fixed Dose Combinations and Formulations Comprising ETC1002 and Ezetimibe and Methods of Treating or Reducing the Risk of Cardiovascular Disease
Application:
62/133,128 →
Fixed Dose Combinations and Formulations Comprising ETC1002 and Ezetimibe and Methods of Treating or Reducing the Risk of Cardiovascular Disease
Application:
62/250,921 →
Fixed Dose Combinations and Formulations Comprising ETC1002 and One or More Statins and Methods of Treating or Reducing the Risk of Cardiovascular Disease
Application:
62/133,739 →
Fixed Dose Combinations and Formulations Comprising ETC1002 and One or More Statins and Methods of Treating or Reducing the Risk of Cardiovascular Disease
Application:
62/277,403 →
Triplet Combination Formulations and Methods of Treating or Reducing the Risk of Cardiovascular Disease
Application:
62/456,571 →
Triplet Combination Formulations and Methods for Treating or Reducing the Risk of Cardiovascular Disease
Application:
16/484,704 →
Publication:
US 2021/0361618
Fixed Dose Formulations
Application:
62/511,889 →
Sustained Release Formulations of Bempedoic Acid
Application:
62/774,083 →
Combination drug formulations for treating patients with cardiovascular disease and associated conditions
Application:
62/723,441 →
Method for Reducing Diabetes in Patients Receiving Statin Therapy
Application:
62/722,766 →
Methods for Reducing the Risk of Diabetes in Patients Being Treated for High Cholesterol-Related Illnesses
Application:
62/751,404 →
Methods for Reducing the Risk of Diabetes in Patients Being Treated for High Cholesterol-Related Illnesses
Application:
17/271,045 →
Publication:
US 2021/0322376
Fixed Dose Combinations and Formulations Comprising ETC1002 and Ezetimibe and Methods of Treating or Reducing the Risk of Cardiovascular Disease
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 16, 2003
From: DASSEUX, JEAN-LOUIS HENRI; ONICIU, CARMEN DANIELA
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 014599/0889 →
Assignment of Assignor's Interest
Aug 10, 2015
From: NEWTON, ROGER SCHOFIELD; ROSENBERG, NOAH LABAN; MACDOUGALL, DIANE ELAINE
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 036288/0675 →
Assignment of Assignor's Interest
Oct 5, 2015
From: NEWTON, ROGER SCHOFIELD; ROSENBERG, NOAH LABAN; MACDOUGALL, DIANE ELAINE
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 036725/0252 →
Assignment of Assignor's Interest
Nov 17, 2016
From: NEWTON, ROGER SCHOFIELD; ROSENBERG, NOAH LABAN; MACDOUGALL, DIANE ELAINE
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 040363/0743 →
Assignment of Assignor's Interest
Jan 12, 2017
From: NEWTON, ROGER SCHOFIELD; ROSENBERG, NOAH LABAN; MACDOUGALL, DIANE ELAINE
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 040967/0762 →
Assignment of Assignor's Interest
Apr 12, 2017
From: LALWANI, NARENDRA; MACDOUGALL, DIANE
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 041988/0091 →
Assignment of Assignor's Interest
Nov 2, 2017
From: PILGAONKAR, PRATIBHA S; GANDHI, ANILKUMAR S.
To: RUBICON RESEARCH PVT. LTD.
Reel/Frame 044012/0663 →
Assignment of Assignor's Interest
Nov 2, 2017
From: ABDELNASSER, MOHAMED
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 044012/0660 →
Assignment of Assignor's Interest
Nov 6, 2017
From: RUBICON RESEARCH PVT. LTD.
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 044040/0235 →
Assignment of Assignor's Interest
May 23, 2018
From: RUBICON RESEARCH PVT. LTD.
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 045884/0750 →
Assignment of Assignor's Interest
Feb 19, 2019
From: LALWANI, NARENDRA DHANRAJ; ABDELNASSER, MOHAMED; PINKOSKY, STEPHEN LAWRENCE; CRAMER, CLAY THOMAS
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 048374/0449 →
Security Interest
Jun 28, 2019
From: ESPERION THERAPEUTICS, INC.
To: EIGER III SA LLC, AS PURCHASER AGENT
Reel/Frame 049623/0629 →
Assignment of Assignor's Interest
Oct 6, 2019
From: LALWANI, NARENDRA; MACDOUGALL, DIANE ELAINE
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 050634/0057 →
Assignment of Assignor's Interest
Oct 15, 2019
From: LALWANI, NARENDRA DHANRAJ
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 050723/0246 →
Assignment of Assignor's Interest
Oct 25, 2019
From: LALWANI, NARENDRA DHANRAJ
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 050829/0946 →
Assignment of Assignor's Interest
Oct 25, 2019
From: NEWTON, ROGER SCHOFIELD; ROSENBERG, NOAH LABAN; MACDOUGALL, DIANE ELAINE
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 050823/0885 →
Assignment of Assignor's Interest
Nov 5, 2019
From: LALWANI, NARENDRA DHANRAJ; MACDOUGALL, DIANE ELAINE
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 050919/0008 →
Assignment of Assignor's Interest
Jun 11, 2020
From: PATHEON AUSTRIA GMBH & CO KG
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 052903/0331 →
Assignment of Assignor's Interest
Jun 11, 2020
From: COPP, RICHARD; ABDELNASSER, MOHAMED; CIMARUSTI, CHRISTOPHER M.
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 052903/0153 →
Assignment of Assignor's Interest
Jun 11, 2020
From: SELIG, PHILIPP
To: PATHEON AUSTRIA GMBH & CO KG
Reel/Frame 052903/0182 →
Assignment of Assignor's Interest
Jun 11, 2020
From: LANE, JONATHAN; BARKMAN, MICHAEL; AMIN, RASIDUL; FRANK, MICHELLE
To: CORDEN PHARMA COLORADO, INC.
Reel/Frame 052903/0187 →
Assignment of Assignor's Interest
Jun 11, 2020
From: COOPER, ARTHUR JOHN; GOPAL, DAMODARAGOUNDER
To: OLON RICERCA BIOSCIENCE LLC
Reel/Frame 052903/0209 →
Assignment of Assignor's Interest
Jun 11, 2020
From: CORDEN PHARMA COLORADO, INC.
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 052903/0274 →
Assignment of Assignor's Interest
Jun 11, 2020
From: OLON RICERCA BIOSCIENCE LLC
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 052903/0279 →
Release of Security Interest
Jun 27, 2024
From: EIGER III SA LLC
To: ESPERION THERAPEUTICS, INC.
Reel/Frame 067963/0094 →